HTDS (Hard to Treat Diseases) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Hard to Treat Diseases's cash flow from discontinued operations for the three months ended in . 20 was $0.00 Mil. It means Hard to Treat Diseases received $0.00 Mil from the sale of part of business quarterly. Hard to Treat Diseases's cash flow from discontinued operations for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Hard to Treat Diseases Cash Flow from Discontinued Operations Historical Data

The historical data trend for Hard to Treat Diseases's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Cash Flow from Discontinued Operations Chart

Hard to Treat Diseases Annual Data

Trend

Cash Flow from Discontinued Operations

Hard to Treat Diseases Quarterly Data

Cash Flow from Discontinued Operations

Hard to Treat Diseases Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Hard to Treat Diseases Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762

Website

http://www.htdsmedical.com

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases Headlines

No Headlines